Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Effectiveness of Ribociclib Following Radiation Therapy in Children with Newly-diagnosed Diffuse Pontine Gliomas

Effectiveness of Ribociclib Following Radiation in Children with Diffuse Pontine Gliomas

Description:

For complete information, please view the study on clinicaltrials.gov

This study is being done in collaboration with Cincinnati Children's Hospital.

Study Status:

Closed

Full IRB Study Title:

CLEE011XUS17T: A Phase I/II Study of Ribociclib, a CDK4/6 Inhibitor, Following Radiation Therapy in Children with Newly-diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High-grade Gliomas (HGG)

IRB Study ID:

969528-2

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...